Prospective evidence on the extent to which serum lipid concentrations in older persons respond to dietary modification is scarce. It is not clear whether such behavioral changes are relevant in the context of more commonly initiated treatments with lipid-lowering drugs. We therefore examined whether individual changes in the consumption of dietary fatty acids or main food sources were associated with changes in the serum lipid profile of older Australians. A total of 903 participants ($49 y) in the Blue Mountains Eye Study had complete data on fasting lipids and dietary intake from a validated FFQ at baseline (1992)(1993)(1994) and 5-and 10-y follow-up examinations. Decreasing consumption of SFA and butter during the 10-y period were associated with moderate decreases in serum total cholesterol independently of initiation of lipid-lowering drug treatment [adjusted estimates were 0.018 6 0.007 mmol/(L x % energy (%en) from SFA (P = 0.01) and 0.055 6 0.015 mmol/(L x 5 g butter) (P = 0.0003), respectively]. Increased consumption of (n-3) fatty acids and fish was independently related to modest increases in serum HDL-cholesterol [0.067 6 0.026 mmol/(L x %en from (n-3) fatty acids) (P = 0.01) and 0.010 6 0.004 mmol/(L x 20 g fish) (P = 0.02)] and decreases in log-transformed serum triglyceride concentrations [P = 0.02 for (n-3) fatty acids and P = 0.02 for fish intake]. Hence, 10-y changes in the intake of dietary fatty acids and their food sources appear to have contributed to concurrent improvements in the serum lipid profile of older Australians, independent of concomitantly initiated lipid-lowering drug treatment. J. Nutr. 140: 88-94, 2010. 
Introduction
Recent evidence indicates that dyslipidemia remains an important risk factor for atherosclerosis and coronary heart disease (CHD), 8 even in older age groups (1, 2) . Intervention studies have shown that increases in SFA adversely affect serum concentrations of total cholesterol (TC) and LDL-cholesterol (LDL-C) (3) . By contrast, increases in cis unsaturated fatty acid intakes are considered to yield favorable changes in the serum lipid profile, with the overall benefits of [mainly (n-6)] PUFA slightly exceeding those of monounsaturated fatty acids (MFA) (3) . However, little is known about the extent to which serum lipid concentrations in free-living older persons respond to dietary modifications and whether lifestyle modifications are relevant in the context of more commonly initiated treatments with lipid-lowering drugs (4) .
In the past years, (n-3) fatty acids have been shown to be beneficial for both primary and secondary prevention of cardiovascular disease (5) and other age-related diseases, including eye disease (6, 7) . One principal mechanism for these beneficial effects appears to operate via a reduction of serum triglyceride (TG) concentrations and potentially an increase of HDL-cholesterol (HDL-C) (8) . Clinical studies indicate that these favorable alterations are primarily attributable to marine (n-3) fatty acids (eicosapentaenoic acid and docosapentaenoic acid) (8) ; evidence on the beneficial effects of plant a-linolenic acid (LNA) on TG and HDL-C is still scarce and inconsistent (9) . Furthermore, epidemiological data on the role of (n-3) fatty acid intakes in the maintenance of healthy lipid concentrations are limited and come mainly from Asian populations where high intakes of fish prevail (10, 11) . It is not known whether a moderate habitual consumption of (n-3) fatty acids in free-living older persons influences their serum lipid profile or, perhaps more importantly, whether dietary changes at this stage of life would be accompanied by concurrent beneficial changes in lipid profile.
Our purpose in this study was to examine whether individual changes in the consumption of dietary fatty acids and the principal contributing food groups during the 5-and 10-y follow-up of a population-based cohort of older Australians would yield concurrent changes in serum TC, HDL-C, or TG concentrations.
Materials and Methods
Study population. The Blue Mountains Eye Study (BMES) is a population-based cohort study of vision, common eye diseases, and other health outcomes in an urban, predominantly Caucasian population aged $49 y. The 1992-94 baseline study ( Dietary assessment. Dietary data were collected using a 145-item FFQ modified for the Australian diet and vernacular from an early Willett questionnaire (12) . The FFQ included details about the type of margarines, butters, and oils used to permit a more detailed analysis of fatty acids. This FFQ has been validated against 4-d weighed food records collected on 3 occasions during 1 y (n = 79) and had moderate to good agreement for ranking individuals according to their fat intakes, yielding correlation coefficients of r = 0.76 (P , 0.0001) for SFA, r = 0.54 (P , 0.0001) for MFA, and r = 0.44 (P , 0.0001) for PUFA.
Nutrient intakes were estimated using the Australian Tables of Food  Composition (NUTTAB90 for BMES 1 and NUTTAB95 for BMES 2 and  BMES 3 ) and its fatty acid supplement and additional fatty acid food composition data were added from the RMIT database available on FoodWorks, version 3 (Xyris Software). For newly developed products not included in NUTTAB95, in particular for margarines, butters, and oil, open-ended questions about brand and type were used and matched to additional fatty acid databases to adequately account for changes in the composition of dietary fatty acids since 1995. Long-chain (n-3) PUFA [(n-3) LC-PUFA] was calculated by summing intakes of eicosapentaonic acid [20:5 (n-3) ], docosapentaenoic acid [22:5 (n-3)], and docosahexaenoic acid [22:6 (n-3)]. Total (n-3) PUFA intake also included LNA [18:3 (n-3)] (13).
Serum lipid concentrations.
Fasting blood specimens were drawn, centrifuged on site, and then sent by courier within the same day to the Westmead Hospital, Sydney, for hematological analysis and clinical biochemistry assessment. Serum TC, HDL-C, and TG concentrations were measured on a Reflotron reflectance photometric analyzer [Boehringer Mannheim Diagnostics (currently Roche Diagnostics)]. CV for repeated measurements of plasma were 2.9% for TC, 3.2% for HDL-C, and 1.4% for TG. Serum LDL-C concentrations were calculated using the Friedewald equation in participants with fasting serum TG concentrations ,4.52 mmol/L (14) .
Assessment of confounding factors. Measured weight and height were used to calculate BMI (kg/m 2 ). A standardized intervieweradministered questionnaire was used to ascertain demographic information, family history, medications taken, past medical history, and lifestyle factors. Information on all currently taken medications was considered to determine the use of cholesterol-lowering medication (statins, fibrates, or bile acid sequestrants). A history of CHD (angina or myocardial infarction) at baseline was combined and termed any CHD at baseline. Diabetes at baseline was defined on the basis of either past history of diabetes and current diabetes treatment or a fasting plasma glucose concentration $7.0 mmol/L at baseline. Cigarette smoking was categorized as current or former smoking at baseline. Postsecondary school qualification was defined as attainment of qualifications (certificate, diploma, or degree) after leaving school. Menopausal status at baseline and use of hormone replacement therapy (ever) were based on self-reports of the women at baseline. Self-rated health at baseline was considered good if participants rated themselves as being in "excellent" or "good" health.
Study sample. Because we were interested in examining 10-y changes in dietary intakes and serum lipids, the present analysis of longitudinal associations between dietary fat intake and serum lipids was restricted to participants who provided a complete and plausible FFQ as well as a blood specimen on all 3 follow-up examinations. Of the 3654 participants examined at BMES 1, the FFQ was attempted and returned by 3267 baseline participants (89.4%); 2897 (79.3% of total participants) had sufficiently complete and plausible FFQ data for analysis. Participants were excluded if 12 questions were missing, if an entire page remained blank, or if daily energy intakes were ,2500 kJ or .18,000 kJ (15) . Of the 2686 participants who provided both plausible dietary intake data and a blood sample at BMES 1, 1086 died during the 10-y follow-up period, 161 were lost to follow-up, and 546 participated in both BMES 2 and BMES 3 but did not provide a plausible FFQ and/or a blood sample. A total of 913 participants had dietary data and blood specimen at all 3 examinations. Another 10 participants were excluded because of missing baseline data on BMI, use of lipid-lowering medication, diabetes mellitus, CHD, or smoking status. Hence, the present examination included 903 participants for analyses of TC and HDL-C. At BMES 3 some participants provided only nonfasting blood specimen; hence, fasting TG concentrations from all 3 visits were only available for 796 participants and LDL-C could be calculated for 773 participants.
Statistical methods. Statistical analyses were performed using SAS software (version 9.1, SAS). Analyses indicated no interactions between sex and the longitudinal relations of dietary fatty acid intake with serum lipid concentrations. The data from women and men were therefore pooled for all analyses.
Because some of the metabolic and nutritional data were not normally distributed, all continuous data are presented as medians (25th and 75th percentiles). Trends in use of cholesterol-lowering medications, metabolic variables, and nutritional intake data between baseline and the 10-y follow-up were examined using Mantel-Haenszel chi-square for categorical data and Kruskal-Wallis test for continuous data.
We used linear mixed effects regression models (PROC MIXED in SAS) to construct longitudinal models of trends in serum TC, LDL-C, and HDL-C and fasting TG between baseline and endpoint. Because fasting serum TG values were not normally distributed, they were logtransformed prior to regression analyses. To account for the lack of independence that exists between repeated observations for the same person, the structure of the within-subject errors was specified using the repeated statement of the MIXED procedure. The Akaike Information Criterion and the Bayesian Information Criterion were used to select the covariance structure best describing the repeated-measures correlation: Toeplitz covariance structure in models for TC and LDL-C, heterogeneous Toeplitz covariance structure in models for HDL-C, and unstructured covariance in models for log-transformed TG.
Intakes of dietary fatty acids or the principal contributing food groups and time (time, time 2 ) were the principal fixed effects. Fatty acid intakes [SFA, MFA, PUFA, (n-3) fatty acids, (n-3) LC-PUFA, and LNA] were energy adjusted using the multivariate energy density model (16) . Intakes of principal fat-contributing food groups were energy adjusted using the energy partition model, e.g. butter consumption was adjusted for energy intake from all other foods. The estimates reflect the effects of "adding" the respective food group, comprising both its energy and nonenergy effect (16) . Baseline measures were set to time = 0 and time at the successive measurements corresponded to the individual time lapsed
Dietary fat quality and serum lipids in older age 89 since baseline. The analyses yielded 3 regression coefficients representing the following: 1) cross-sectional estimate, regressing dietary fatty acid intake at baseline on serum lipid concentrations at baseline; 2) prospective estimate, the slope of these dietary variables at baseline on the change in serum lipids over the study period; and 3) concurrent 10-y change estimate, the slope of the change in these dietary variables over the study period on the concurrent change in serum lipids. The change in dietary fatty acid intakes over the study period was calculated by subtracting baseline intake levels from the intake at follow-up visits.
For the full model, the fixed effects of age, sex, diabetes mellitus, current or former smoking, any CHD, and high qualification or good self-rated health at baseline were also considered as potential confounding factors. Additionally, BMI, other nutritional variables (i.e. dietary fiber, glycemic index, or alcohol consumption) and use of cholesterollowering medications were considered, including their level at baseline, baseline level 3 time, or change in their level during the study period. Only those potential confounding factors that: 1) substantially modified the association of the principal dietary variables with serum lipids in the unadjusted models; 2) significantly predicted the outcome variable; or 3) improved the fit statistic (Akaike's information criterion) were included in the full model. Finally, we conducted post-hoc power analyses using PROC MIXED. Results from these analyses need to be interpreted cautiously and may provide only an indication as to whether the presented concurrent change estimates are reasonably powered (17) . All analyses were performed with significance level at P , 0.05.
Results
The 903 BMES participants included in these analyses ( Table 1) were significantly younger and were more likely to be women, have a postsecondary school qualification, and good selfreported health at baseline but were less likely to smoke or to suffer from diabetes or CHD than the 1086 participants who died during follow-up. Those who died during follow-up had had higher TG and lower TC concentrations than those included in the analysis and they had consumed less LNA, nuts, and butter at BMES 1. The 697 participants who were lost to followup or did not provide complete dietary and lipid data were older, less likely to have a postsecondary school qualification and a good self-reported health at baseline, and had consumed less PUFA and nuts at BMES 1 than the 903 individuals included in this analysis.
During the 10-y follow-up, BMI increased significantly, but serum concentrations of TC, calculated LDL-C, and TG decreased, whereas HDL-C concentrations and the use of cholesterol-lowering medication increased ( Table 2) . At baseline, 36 (82%) of the 44 participants taking cholesterol-lowering medication were on statins, 8 (18%) took fibrates. At subsequent visits, the percentage of statin users increased to .95%.
Ten-year changes in dietary intake included increases in MFA, all PUFA fractions, and fish and decreases in margarine consumption (Table 2) . Overall, SFA intake tended to increase only slightly (P = 0.1). Nonetheless individual changes were considerable: 38% of the participants increased and 36% decreased their SFA intake by at least 1%en between BMES 1 and BMES 3. Overall, butter consumption remained at a relatively low level; however, the 257 (28%) participants who had consumed $5 g/d butter at baseline decreased their intake significantly from a median of 17.5 g/d to 5.5 g/d (P , 0.0001). Participants who experienced an increase in serum TC between BMES 1 and BMES 3 had increased their overall SFA intake by 0.29% of energy between BMES 1 and BMES 3, whereas those with moderate declines in TC (by ,1 mmol/L) or notable declines in TC (by $1 mmol/L) reduced their SFA intake by 0.26% of energy and 0.27% of energy, respectively (P = 0.08 for difference between the groups).
In the more comprehensive change-on-change analysis based on all 3 measurements, increases in SFA intake during the 10-y follow-up were accompanied by concurrent increases in serum TC; for each increase in SFA by 1% serum TC increased by 0.018 mmol/L (P = 0.01) ( Table 3 , second column). A stronger association was observed before adjusting for the initiation of cholesterol-lowering drug treatment for serum TC [estimate (0.025 6 0.008) mmol/(L 3 % energy (%en) from SFA) (P = 0.002) in models adjusting for age, sex, and energy only] and LDL-C [0.020 6 0.008 mmol/(L 3 %en from SFA) (P = 0.01)]. Increases in SFA intake were also associated with higher serum HDL-C concentrations (P = 0.004) ( Table 4 , second column). However, the ratio of TC:HDL-C was not independently related to SFA intake, cross-sectionally (P = 0.8) or concurrently (P = 0.6) (data not shown).
For (n-3) PUFA intake, the comprehensive change-on-change analysis revealed concurrent associations with serum HDL-C and TG concentrations (P = 0.01 and P = 0.02) ( Table 4 , second and 4th column). For each 1% increase in intake of (n-3) PUFA by 1% during the 10-y follow-up, serum HDL-C increased by 0.067 mmol/L (P = 0.01) ( Table 4 , second column). With respect to subgroups of (n-3) PUFA, increases of LNA were associated with increases in serum HDL-C concentrations (P = 0.02) and increases of (n-3) LC PUFA tended to be related to increases in HDL-C (P = 0.1). For serum TG concentrations, similar 10-y concurrent change estimates were observed for LNA PUFA (P = 0.05).
Analyses for (n-6) PUFA did not reveal any associations with TC, LDL-C, and TG. Only a trend toward higher serum HDL-C concentrations was seen with a higher (n-6) PUFA intake (P = 0.08), which did not persist when (n-3) PUFA was added to the model (P = 0.3) (data not shown).
Increases in butter consumption were related to concomitant increases in serum TC (P = 0.0003) and LDL-C (P = 0.003) and a tendency toward an increase in serum HDL-C (P = 0.09) ( Table  5) . However, the ratio of TC:HDL-C was not associated with butter consumption, cross-sectionally (P = 0.2) or concurrently (P = 0.5) (data not shown). Conversely, increases in fish consumption yielded increases in serum HDL-C (P = 0.02) and decreases in serum TG concentrations (P = 0.02). Post hoc power analyses indicated that the power to detect concurrent changes was generally higher for foods than for nutrients; the power for the concurrent change estimate for serum TC was 56% for SFA intake but 83% for butter, for the concurrent change estimate for serum HDL the power was 70, 33, and 57% for (n-3) fatty acids, (n-3) LC-PUFA, and LNA, respectively, but 76% for fish intake. Additional analyses indicated an interaction with the presence of CHD at baseline for the change-on-change association between butter consumption and serum TC (P = 0.04 for interaction) or serum LDL-C concentrations (P for interaction = 0.02). Among the 97 participants with CHD at baseline, concurrent changes were more pronounced [0.129 mmol/(L serum TC 3 5 g butter) (P = 0.03) and 0.131 mmol/(L serum LDL-C 3 5 g butter) (P = 0.03)] than in those free of CHD at baseline [0.045 mmol/(L serum TC 3 5 g butter) (P = 0.004) and 0.035 mmol/(L serum LDL-C 3 5 g butter) (P = 0.02)].
Discussion
The present 10-y follow-up study in free-living, older Australians suggests that individual changes in the quality of dietary fat affected their serum lipid concentrations. Specifically, individual decreases in SFA intake and butter consumption as well as increases in (n-3) fatty acids and fish consumption appear to have translated into beneficial changes in their serum lipid profiles. These dietary effects were observed over and above the effects of statins, the principal lipid-lowering medication that was commenced in this period.
In this study, dietary fatty acid intake and the choice of fat-contributing food groups improved markedly between 1992-1994 (BMES 1) and 2002-2004 (BMES 3). Simultaneously, lipid-lowering medications were more widely adopted. These trends are consistent with changes observed in the Minnesota Heart Survey (4). When statin treatment became more widely available, some clinical trials suggested additive effects of diet and statin treatment (18, 19) , whereas others reported that statins blunted the effects of dietary changes (20, 21) . In the present study, baseline cholesterol-lowering medication status (mostly statin treatment) did not modify the investigated change-on-change associations between diet and serum lipid concentrations (data not shown). However, adjustment for the initiation/discontinuation of drug treatment among 1 Models adjust for age, sex, presence of diabetes mellitus, and presence of CHD at baseline as well as energy intake, the use of cholesterol-lowering medication, and BMI (each as baseline values, baseline values 3 time, and concurrent 10-y change), i.e. energy intake was adjusted for using the multivariate energy density model. Models contain a repeated statement with an Toeplitz covariance structure (toep). 2 Cross-sectional estimate: difference in serum TC or LDL-C concentrations at baseline associated with a 1% higher energy intake from the respective fatty acid; 10-y concurrent change estimate: change in serum TC or LDL-C concentrations associated with a 1% increase in energy from the respective fatty acid over the 10-y period.
Dietary fat quality and serum lipids in older age 91 BMES 1, BMES 2, and BMES 3 attenuated the concurrent association of SFA intake with serum TC and calculated LDL-C concentrations.
The overall effect of dietary intakes on serum TC and LDL-C was small; an increase in butter consumption by 5 g (1 teaspoon) over the 10-y observational period was, on average, associated with an increase in TC by 0.06 mmol/L and an increase in SFA intake by 1% with an increase in serum TC by 0.02 mmol/L. Effect estimates for calculated serum LDL-C were even smaller, but this may reflect the tendency of the Friedewald formula to underestimate LDL-C at lower serum TG concentrations (22) . The overall decrease in serum TG concentrations over the 10-y observational period may have resulted in an increasing bias, thus hampering the accurate estimation of change in serum LDL-C concentrations during follow-up. Not surprisingly, somewhat larger changes can be obtained in intervention studies. In their meta-analysis of 60 controlled trials, Mensink et al. (3) estimated a mean increase in serum TC by 0.04 mmol/L for each percent of energy from carbohydrates iso-energetically replaced with SFA. Our observational results thus appear plausible and suggest that SFA intake affects serum TC and LDL-C concentrations over the longer term in older free-living adults but that these effects are relatively small.
Our observation that individual increases in butter or SFA intake were also associated with increases in serum HDL-C is again in accordance with controlled trials (3) . As in the metaanalysis (3), we did not observe a relationship with the ratio of TC:HDL-C, because serum TC and HDL-C increased to comparable degrees. Controlled trials also suggest moderate decreases in TC and LDL-C when (n-6) PUFA is increased (23) . However, dietary changes made by the elderly BMES participants during the 10-y follow-up were apparently not sufficient to disentangle such moderate concurrent changes in serum TC or LDL-C.
In this study, an increased consumption of (n-3) fatty acids and fish yielded small but consistent benefits for the concentrations of both serum HDL-C and TG. The TG-lowering effect of higher doses of (n-3) fatty acids and fish oil in humans is well established from intervention studies (8) but not confirmed for moderate habitual intake levels in free-living individuals. For serum HDL-C, the INTERLIPID Study recently reported a cross-sectional association with (n-3) LC-PUFA in a pooled analysis of 4 Japanese and 1 Japanese-American population amounting to~0.12 mmol/[L 3 %en from (n-3) LC-PUFA] (10). Despite the considerably lower (n-3) LC-PUFA intake levels in our population, our cross-sectional estimate was somewhat larger [0.23 mmol/(L 3 %en (n-3) LC-PUFA)]. Hence, even modest improvements in these lipid variables could partially explain the numerous benefits observed with higher intakes of (n-3) fatty acids and fish (5) (6) (7) (8) .
TABLE 4 Mixed models of the cross-sectional and the 10-y concurrent relations of dietary fatty acid intakes to serum HDL-C concentrations and log-transformed serum TG concentrations in BMES participants
Serum HDL-C, 1 n = 903 Log-transformed serum TG, 2 n = 796
Cross-sectional estimate 3 10-y concurrent change estimate 3 Cross-sectional estimate 3 10-y concurrent change estimate 1 Models adjust for age, sex, presence of diabetes mellitus, and presence of CHD at baseline, and current smoking at baseline, as well as energy intake, BMI, and alcohol intake (each as baseline values, baseline values 3 time, and concurrent 10-y change), i.e. energy intake was adjusted for using the multivariate energy density model. Model contains a repeated statement with an heterogeneous Toeplitz covariance structure (toeph). 2 Models adjust for age, sex, presence of diabetes mellitus, and current smoking at baseline as well as energy intake, the use of cholesterol-lowering medication, BMI, and alcohol intake (each as baseline values, baseline values 3 time, and concurrent 10-y change), i.e. energy intake was adjusted for using the multivariate energy density model. Model contains a repeated statement with an unspecified covariance structure (un). 3 Cross-sectional estimate: difference in serum lipid concentrations at baseline associated with a 1% higher energy intake from the respective fatty acid; 10-y concurrent change estimate: change in serum lipid concentrations associated with a 1% increase in energy from the respective fatty acid over the 10-y period. Serum TC, n = 903 Calculated LDL-C, n = 773 Serum HDL-C, n = 903 Log-transformed serum TG, n = 796 It is currently debated whether the benefits of (n-3) fatty acids are almost exclusively due to (n-3) LC-PUFA or whether some benefits may also be attributed to LNA (5, 24) . In the present study, concurrent associations with fasting serum TG and HDL-C were significant for LNA and fish consumption, but not for (n-3) LC-PUFA. The fact that the 10-y prospective estimates for (n-3) LC-PUFA in relation to serum TG were comparable (but nonsignificant) to those for total (n-3) fatty acids suggests that (n-3) LC-PUFA may have been one of the biologically relevant subgroups. Post-hoc power analyses suggest that we may have lacked the power to extract this association, because intake of (n-3) LC-PUFA accounts for only a small proportion of the daily energy intake. Nonetheless, recent evidence suggests that a cardioprotective effect of LNA may be evident mostly among individuals with low LNA intakes (24) . Because LNA intake levels in the present cohort were relatively low (13) , it is conceivable that increases in their LNA intakes could yield benefits such as those seen in this study for serum HDL-C and TG concentrations.
The key strengths of the present analysis include its prospective nature with repeated detailed measurement of both serum lipids and dietary data in a population-based contemporary sample. We could control for repeatedly measured key confounding factors such as the BMI and the initiation/discontinuation of lipid-lowering drug treatment and could corroborate our results obtained from nutrient intakes with data on the main contributing food groups.
Nonetheless, we cannot preclude residual confounding resulting from imprecisely measured or unmeasured confounding factors. We could not control for concurrent changes in physical activity levels; however, consideration of physical activity at baseline was not related to any of the investigated associations. Furthermore, the level of regular physical exercise needed to affect HDL-C is quite substantial (25) and unlikely to have been undertaken by a substantial number of the elderly BMES participants. In addition, adjustment for energy intake may indirectly control for an important aspect of physical activity. Finally, additional consideration of BMI could be considered an overadjustment for energy intake; however, changes in BMI among the elderly are likely to be complex, comprising of factors other than energy balance, and analyses without BMI yielded similar results (data not shown).
Because we have examined many associations, the possibility of chance findings cannot be excluded. During the 5-and 10-y follow-up, participants may have had a greater recall of certain food groups such as fish intake as the knowledge of their health benefits became more common. However, such a recall bias would have translated into an underestimation of the estimates for the concurrent change in serum lipid concentrations. Selection bias may hamper the extent to which our results can be generalized. Similar characteristics among those lost to follow-up suggest that attrition bias was low; however, selective survival may have occurred, because those included in the analysis were notably healthier at baseline than those who died during follow-up. Persons who have a high 10-y risk to die of CHD or cancer may not be as susceptible to changes in dietary fat intakes. On the other hand, we did show a more pronounced concurrent change association among those with CHD at baseline, at least with respect to the benefits of a reduction in butter consumption.
In summary, our study shows that free-living older Australians made sustained changes to their intake of dietary fatty acids and contributing food groups between 1992 and 2002. These changes were associated with concurrent decreases in TC and TG concentrations and an increase in HDL-C independently of concomitantly initiated lipid-lowering drug treatment. Thus, modifications in dietary fat quality may contribute to improvements in the serum lipid profile of older persons beyond lipidlowering medication.
